Influence of Renal Function on the Use of Guideline-Recommended Therapies for Patients With Heart Failure
To access this article, please choose from the options below
The IMPROVE HF registry and this study were sponsored by Medtronic, Inc., Minneapolis, MN.
The authors served as consultants to Medtronic, Inc.; as of June 2008, this association ended for Dr. Yancy.
Dr. McBride is a consultant to Outcome Sciences, Inc., Cambridge, Massachusetts.
PII: S0002-9149(09)02846-X
doi:10.1016/j.amjcard.2009.12.016
© 2010 Published by Elsevier Inc.
